JACC: Case Reports (Sep 2020)

Coronary Artery Aneurysm After Drug-Eluting Stent Implantation Causing Coronary-Bronchial Fistula

  • Ankush Gupta, MD, DM,
  • Rajat Datta, MD, DM,
  • Sanya Chhikara, MBBS,
  • Peeyush K. Dhagat, MD,
  • Rajesh Vijayvergiya, MD, DM

Journal volume & issue
Vol. 2, no. 11
pp. 1692 – 1697

Abstract

Read online

Coronary artery aneurysm (CAA) after drug-eluting stent implantation is rare, with a reported incidence of 0.3% to 6.0%. Most of these aneurysms are asymptomatic. Hemoptysis as a presentation of CAA is very rare. The patient in our case had CAA after zotarolimus-eluting stent implantation and presented with hemoptysis resulting from a leaking coronary-bronchial fistula. (Level of Difficulty: Intermediate.)

Keywords